Pietruczuk A - Search Results

1

Factors Influencing Longevity of Humoral Response to SARS-CoV-2 Vaccination in Patients with End Stage Kidney Disease Receiving Renal Replacement Therapy.

Glowinska I, Labij-Reduta B, Juzwiuk J, Lukaszewicz M, Pietruczuk A, Poplawska A, Daniluk-Jamro A, Kakareko K, Rydzewska-Rosolowska A, Naumnik B, Koc-Zorawska E, Zorawski M, Hryszko T. Glowinska I, et al. Among authors: pietruczuk a. J Clin Med. 2022 Aug 25;11(17):4984. doi: 10.3390/jcm11174984. J Clin Med. 2022. PMID: 36078913 Free PMC article.

2

Long-Term Safety and Efficacy of Subcutaneous Cladribine Used in Increased Dosage in Patients with Relapsing Multiple Sclerosis: 20-Year Observational Study.

Rejdak K, Zasybska A, Pietruczuk A, Baranowski D, Szklener S, Kaczmarek M, Stelmasiak Z. Rejdak K, et al. Among authors: pietruczuk a. J Clin Med. 2021 Nov 8;10(21):5207. doi: 10.3390/jcm10215207. J Clin Med. 2021. PMID: 34768726 Free PMC article.

3

[Review of diagnostic criteria for multiple sclerosis].

Pietruczuk A, Zsybska A, Rejdak K, Papuć E. Pietruczuk A, et al. Wiad Lek. 2018;71(7):1365-1371. Wiad Lek. 2018. PMID: 30448812 Review. Polish.

4

The Mössbauer study of atmospheric iron-containing aerosol in the coarse and PM2.5 fractions measured in rural site.

Kopcewicz B, Kopcewicz M, Pietruczuk A. Kopcewicz B, et al. Among authors: pietruczuk a. Chemosphere. 2015 Jul;131:9-16. doi: 10.1016/j.chemosphere.2015.02.038. Epub 2015 Mar 9. Chemosphere. 2015. PMID: 25765259

5

[Vascular adhesion protein-1 (VAP-1) in inflammatory process].

Pietruczuk M, Pietruczuk A, Zajkowska J, Pancewicz S, Hermanowska-Szpakowicz T. Pietruczuk M, et al. Among authors: pietruczuk a. Przegl Lek. 2006;63(4):220-2. Przegl Lek. 2006. PMID: 17083159 Review. Polish.

6

[Intercellular adhesion molecules sICAM-1, sICAM-2, sICAM-3 and IFNgamma in neuroborreliosis and tick-borne encephalitis].

Pietruczuk M, Pietruczuk A, Pancewicz S, Zajkowska J, Swierzbińska R, Hermanowska-Szpakowicz T. Pietruczuk M, et al. Among authors: pietruczuk a. Przegl Epidemiol. 2006;60 Suppl 1:109-17. Przegl Epidemiol. 2006. PMID: 16909787 Clinical Trial. Polish.

7

Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis.

Pietruczuk A, Swierzbińska R, Pancewicz S, Pietruczuk M, Hermanowska-Szpakowicz T. Pietruczuk A, et al. Infection. 2006 Jun;34(3):158-62. doi: 10.1007/s15010-006-5013-z. Infection. 2006. PMID: 16804660

8

[ICAM-1: structure, biological role and clinical significance].

Pietruczuk M, Pietruczuk A, Pancewicz S, Hermanowska-Szpakowicz T. Pietruczuk M, et al. Among authors: pietruczuk a. Pol Merkur Lekarski. 2004 Nov;17(101):507-11. Pol Merkur Lekarski. 2004. PMID: 15754645 Review. Polish.

9

[Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis].

Pietruczuk A, Swierzbińska R, Pietruczuk M, Hermanowska-Szpakowicz T. Pietruczuk A, et al. Pol Merkur Lekarski. 2004 Nov;17(101):446-50. Pol Merkur Lekarski. 2004. PMID: 15754629 Polish.

10

[Concentration of interleukin-18, interleukin-1beta, soluble receptor for interleukin-1 (sIL-1RII) and C-reactive protein in patients with neuroborreliosis].

Pietruczuk A, Swierzbińska R, Pietruczuk M, Kondrusik M, Zajkowska J, Pancewicz S, Hermanowska-Szpakowicz T. Pietruczuk A, et al. Neurol Neurochir Pol. 2005 Jan-Feb;39(1):33-9. Neurol Neurochir Pol. 2005. PMID: 15735988 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page